Month: July 2021

ROSEVILLE, Minn., July 07, 2021 (GLOBE NEWSWIRE) — SecureTech Innovations, Inc. (OTC: SCTH), an emerging growth company focused on developing and marketing personal and automobile security and safety devices and technologies, announces the launching of a Top Kontrol YouTube Channel to promote and educate the public on the superior capabilities of Top Kontrol anti-theft and anti-carjacking system. Over the coming weeks and months, SecureTech will be releasing a series of Top Kontrol demonstration videos presently being filmed and edited by Cross Stitch Media to this YouTube Channel. SecureTech urges its followers and shareholders to visit and subscribe to the Top Kontrol YouTube Channel at youtube.com/channel/UC40dT7GnkbHLdiAy1IRxQMQ. Kao Lee, SecureTech’s President and CEO, stated, “We are incredibly pleased to be moving forward...

Ms. Rotunno brings extensive healthcare industry expertise as a leader and strategist as VistaGen advances late-stage development of its product candidates for anxiety and depression disorders SOUTH SAN FRANCISCO, Calif., July 07, 2021 (GLOBE NEWSWIRE) — VistaGen Therapeutics, Inc. (NASDAQ: VTGN), a biopharmaceutical company committed to developing a new generation of medicines with the potential to go beyond the current standard of care for anxiety, depression and other central nervous system (“CNS”) disorders, today announced the appointment of Mary L. Rotunno, J.D. to its Board of Directors (“Board”). “Mary brings to our team more than 30 years of leadership experience, which began with serving patients as a registered nurse and transitioned to serving clients in health care law, both allowing her to pursue her steadfast commitment...

MAP1ENmap1MAP2ENmap2MONTREAL, July 07, 2021 (GLOBE NEWSWIRE) — The management of Sirios Resources Inc. (TSXV: SOI) is pleased to announce the commencement of a 2,500-metre diamond drill program on its Cheechoo gold property in Eeyou Istchee James Bay, Quebec. In addition to definition drilling, the program will test exploration targets outside of the limits of the Cheechoo gold deposit, as well as a target at depth on the extension of the deposit itself. From south to north, the first hole will be the deepest of the entire campaign, targeting a possible lateral extension of the Cheechoo deposit to the southeast. The second hole will test the extension of a zone defined by 0.9 g/t Au over 15.7 m (including 1.2 g/t Au over 8.1 m) from hole 129 (ref: press release 04/24/2018) hosted in the meta-graywackes,...

CAMBRIDGE, Mass., July 07, 2021 (GLOBE NEWSWIRE) — Codiak BioSciences, Inc. (Nasdaq: CDAK), a clinical-stage biopharmaceutical company focused on pioneering the development of exosome-based therapeutics as a new class of medicines, today announced that its President and Chief Executive Officer, Douglas E. Williams, Ph.D., will participate in two virtual panel discussions and virtual 1×1 meetings at the William Blair Biotech Focus Conference 2021. Details are as follows: William Blair Biotech Focus Conference 2021Date: Wednesday, July 14Panel: Developing Therapies for the Next Immuno-Oncology TargetsTime: 2:10-3:10 p.m. Date: Thursday, July 15Panel: Non-Viral Drug DeliveryTime: 2:00-2:45 p.m. Live webcasts of the virtual panel discussions will be available on the Investors & Media section of the Codiak website at www.codiakbio.com....

CAMBRIDGE, Mass., July 07, 2021 (GLOBE NEWSWIRE) — Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that Nick Colangelo, President and CEO, will present the latest company overview at the Ladenburg Thalmann Healthcare Conference. The conference is being conducted in a virtual format and the presentation will take place on Tuesday, July 13, 2021, at 9:00 a.m. Eastern Time. A live webcast of the presentation will be available on the Investor Relations section of the Vericel Corporation website at: http://investors.vcel.com. About Vericel CorporationVericel is a leader in advanced therapies for the sports medicine and severe burn care markets. The company markets two cell therapy products in the United States. MACI® (autologous cultured chondrocytes...

ATLANTA, July 07, 2021 (GLOBE NEWSWIRE) — Manhattan Associates Inc. (NASDAQ: MANH) today announced it will release its second quarter 2021 financial results on Tuesday, July 27, 2021, after the stock market closes. The press release will be followed by a conference call hosted by Manhattan Associates’ senior management at 4:30 p.m. Eastern time, also on July 27, 2021. Investors are invited to listen to a live webcast of the conference call through the investor relations section of the Manhattan Associates website at ir.manh.com. To listen to the live webcast, please go to the website at least 15 minutes before the call to download and install any necessary audio software. For those who cannot listen to the live broadcast, a replay can be accessed shortly after the call by dialing +1-855-859-2056 in the U.S. and Canada, or...

VANCOUVER, British Columbia, July 07, 2021 (GLOBE NEWSWIRE) — Ceylon Graphite Corp. (“Ceylon”) (TSX-V: CYL) (OTC: CYLYF) (FSE: CCY) is pleased to announce the execution of a Memorandum of Understanding dated June 30, 2021 (the “MOU”) with two subsidiaries of Lanka ORIX Leasing Company Group (“LOLC”). Pursuant to the MOU, Ceylon Graphite, through its subsidiary, Plumbago Refining Corp B.V. (“Plumbago”), and LOLC, through its subsidiaries LOLC GEO Technologies Ltd. (“LOLCGT”) and LOLC Advanced Technologies Ltd. (“LOLCAT”), will work together to develop new graphite mines outside of the existing Ceylon portfolio, and to construct and operate a state-of-the-art graphite processing facility in Sri Lanka. LOLC is the largest corporate conglomerate in Sri Lanka. It recorded the highest profitability in Sri Lankan corporate history in...

CAMBRIDGE, Mass., July 07, 2021 (GLOBE NEWSWIRE) — Jounce Therapeutics, Inc. (NASDAQ: JNCE), a clinical-stage company focused on the discovery and development of novel cancer immunotherapies and predictive biomarkers, today announced that Dmitri Wiederschain, Ph.D., Chief Scientific Officer will participate in a panel discussion at the William Blair’s Biotech Focus Conference taking place virtually on Wednesday, July 14, 2021 at 4:20 PM ET. A webcast of the panel will be available by visiting “Events and Presentations” in the Investors and Media section of Jounce’s website at www.jouncetx.com. A replay of the webcast will be archived for 30 days following the presentation. About Jounce TherapeuticsJounce Therapeutics, Inc. is a clinical-stage immunotherapy company dedicated to transforming the treatment of cancer by developing...